Payment overview · 2025
General Payments
$68.10
3 reported records · 3 companies
Healthcare provider profile · identity verified
Terence Michael Williams, DO
Allopathic & Osteopathic Physicians|Family Medicine · SAND SPRINGS, OK · NPI 1487685020
Verified facts
What the public records show
CMS Open Payments records show Terence Michael Williams, DO received $68.10 in general payments during 2025 across 3 reported records.
Regeneron Healthcare Solutions, Inc. accounted for 38.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | Unresolved — no canonical attribution shown | $26.14 | 38.4% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $21.54 | 31.6% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $20.42 | 30.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $68.10 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| DUPIXENT Normalized: dupixent |
Biological | Regeneron Healthcare Solutions, Inc. | $26.14 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $21.54 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $21.54 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $20.42 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 432 | 119 |
| Amlodipine Besylate | Amlodipine Besylate | 359 | 84 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 344 | 47 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 327 | 90 |
| Pantoprazole Sodium | Pantoprazole Sodium | 317 | 75 |
| Levothyroxine Sodium | Levothyroxine Sodium | 238 | 65 |
| Alprazolam | Alprazolam | 209 | 31 |
| Gabapentin | Gabapentin | 206 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 193 | 56 |
| Losartan Potassium | Losartan Potassium | 192 | 52 |
| Ozempic | Semaglutide | 192 | 31 |
| Pioglitazone Hcl | Pioglitazone Hcl | 189 | 50 |
| Omeprazole | Omeprazole | 186 | 49 |
| Lisinopril | Lisinopril | 182 | 55 |
| Potassium Chloride | Potassium Chloride | 176 | 42 |
| Metoprolol Succinate | Metoprolol Succinate | 167 | 49 |
| Tramadol Hcl | Tramadol Hcl | 163 | 43 |
| Metformin Hcl | Metformin Hcl | 148 | 46 |
| Diclofenac Sodium | Diclofenac Sodium | 143 | 36 |
| Eliquis | Apixaban | 131 | 25 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 126 | 22 |
| Mirtazapine | Mirtazapine | 115 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 114 | 27 |
| Alendronate Sodium | Alendronate Sodium | 112 | 32 |
| Furosemide | Furosemide | 107 | 35 |
| Trazodone Hcl | Trazodone Hcl | 104 | 26 |
| Tresiba Flextouch U-200 | Insulin Degludec | 104 | 22 |
| Jardiance | Empagliflozin | 103 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 100 | 34 |
| Zolpidem Tartrate | Zolpidem Tartrate | 100 | 15 |
| Carvedilol | Carvedilol | 99 | 28 |
| Mounjaro | Tirzepatide | 97 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 95 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 93 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 91 | 29 |
| Meloxicam | Meloxicam | 91 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 91 | 24 |
| Metformin Hcl Er | Metformin Hcl | 90 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 87 | 26 |
| Baclofen | Baclofen | 82 | 18 |
| Glimepiride | Glimepiride | 82 | 24 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 82 | 19 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 82 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 81 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 80 | 22 |
| Tizanidine Hcl | Tizanidine Hcl | 79 | 14 |
| Montelukast Sodium | Montelukast Sodium | 77 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 70 | 26 |
| Buspirone Hcl | Buspirone Hcl | 66 | 13 |
| Donepezil Hcl | Donepezil Hcl | 66 | 12 |
| Clonazepam | Clonazepam | 65 | 13 |
| Olanzapine | Olanzapine | 63 | 15 |
| Pregabalin | Pregabalin | 61 | 13 |
| Simvastatin | Simvastatin | 60 | 18 |
| Temazepam | Temazepam | 59 | suppressed |
| Mupirocin | Mupirocin | 58 | 35 |
| Farxiga | Dapagliflozin Propanediol | 55 | suppressed |
| Allopurinol | Allopurinol | 54 | 17 |
| Sertraline Hcl | Sertraline Hcl | 52 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | suppressed |
| Rybelsus | Semaglutide | 49 | 11 |
| Azithromycin | Azithromycin | 47 | 40 |
| Celecoxib | Celecoxib | 45 | suppressed |
| Primidone | Primidone | 44 | suppressed |
| Finasteride | Finasteride | 43 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 43 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 42 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 41 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 41 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 40 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 39 | suppressed |
| Xarelto | Rivaroxaban | 39 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 38 | suppressed |
| Torsemide | Torsemide | 37 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | suppressed |
| Lovastatin | Lovastatin | 36 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 35 | suppressed |
| Fenofibrate | Fenofibrate | 34 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Valsartan | Valsartan | 34 | suppressed |
| Prednisone | Prednisone | 33 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 32 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 32 | 11 |
| Estradiol | Estradiol | 32 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 31 | 27 |
| Clonidine Hcl | Clonidine Hcl | 31 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 30 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 29 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Bupropion Xl | Bupropion Hcl | 29 | suppressed |
| Spironolactone | Spironolactone | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 28 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 28 | suppressed |
| Linzess | Linaclotide | 27 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 26 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 25 | suppressed |
| Methylprednisolone | Methylprednisolone | 25 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 24 | suppressed |
| Novolog Flexpen | Insulin Aspart | 24 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 24 | suppressed |
| Belsomra | Suvorexant | 23 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | suppressed |
| Cefdinir | Cefdinir | 22 | 14 |
| Famotidine | Famotidine | 22 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 19 | 15 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 19 | suppressed |
| Lorazepam | Lorazepam | 19 | suppressed |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 19 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Eszopiclone | Eszopiclone | 18 | suppressed |
| Ketoconazole | Ketoconazole | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Alprazolam Er | Alprazolam | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | 15 |
| Rizatriptan | Rizatriptan Benzoate | 17 | suppressed |
| Cephalexin | Cephalexin | 16 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 15 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | 11 |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $68.10 · 3 records | Regeneron Healthcare Solutions, Inc. | DUPIXENT, Dexcom G6 Transmitter, OTEZLA, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error